Comparison between Bio Medica Laboratories IPO and Kanishk Aluminium India IPO.
Bio Medica Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Kanishk Aluminium India IPO is a SME Fixed Price proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Sun Capital Advisory Services Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | ||
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹0.00 Cr whereas the issue size of the Kanishk Aluminium India IPO is up to ₹27.74 Cr. The final issue price of Bio Medica Laboratories IPO is and of Kanishk Aluminium India IPO is ₹73.00 per share.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹73.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | |
| Fresh Issue Size | 32,05,200 shares | 38,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹27.74 Cr |
| OFS Issue Size | 3,76,800 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,82,000 shares | 38,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹27.74 Cr |
Bio Medica Laboratories IPO opens on , while Kanishk Aluminium India IPO opens on Jan 28, 2026. The closing date of Bio Medica Laboratories IPO and Kanishk Aluminium India IPO is , and Jan 30, 2026, respectively.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 28, 2026 | |
| Issue Close | Jan 30, 2026 | |
| Basis Of Allotment (Tentative) | Feb 02, 2026 | |
| Initiation of Refunds (Tentative) | Feb 03, 2026 | |
| Credit of Share (Tentative) | Feb 03, 2026 | |
| Listing date (Tentative) | Feb 04, 2026 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is , as compared to Kanishk Aluminium India IPO P/E ratio of 22.66.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Bio Medica Laboratories Ltd.'s revenue increased by 150% and profit after tax (PAT) rose by 292% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Standalone)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 22.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹98.11 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 20.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 14.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 1.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 20.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 0 shares while in Kanishk Aluminium India IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Bio Medica Laboratories IPO and 0 shares in Kanishk Aluminium India IPO.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,600 shares | 2,00,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 18,99,200 shares |
| RII | 0 shares | 19,00,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 38,00,000 shares |
Bio Medica Laboratories IPO subscribed in total, whereas Kanishk Aluminium India IPO subscribed 1.04x.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.23x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.86x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.04x |
